Hap Trading, LLC Biora Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Call Options

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$0.13 - $12.03 $1,950 - $180,450	-15,000 Reduced 24.47%	46,300 $1,000
Q3 2022 Nov 14, 2022	SELL	$0.53 - $13.3 $27,772 - $696,920	-52,400 Reduced 46.09%	61,300 $2,000
Q2 2022 Aug 12, 2022	SELL	$0.56 - $1.22 $13,832 - $30,134	-24,700 Reduced 17.85%	113,700 $9,000
Q1 2022 May 12, 2022	SELL	$1.11 - $2.25 $92,907 - $188,325	-83,700 Reduced 37.69%	138,400 $9,000
Q4 2021 Feb 14, 2022	BUY	$1.35 - $4.89 $228,960 - $829,344	169,600 Added 323.05%	222,100 $48,000
Q3 2021 Nov 10, 2021	BUY	$0.67 - $3.41 $24,522 - $124,806	36,600 Added 230.19%	52,500 $17,000
Q2 2021 Aug 11, 2021	BUY	$2.11 - $4.93 $33,549 - $78,387	15,900 New	15,900 $5,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $41.1M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.